Cargando...
Deriving meaningful insights from clinical trial and postmarketing safety data: Perspectives from India
Today, drug safety data collection in India is both manual and electronic with reporting of potential overlapping and duplicate data, which is likely incomplete for further review and analysis. Furthermore, standardized data collection and timelines are not aligned with international standards. Comp...
Gardado en:
| Publicado en: | Perspect Clin Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5384402/ https://ncbi.nlm.nih.gov/pubmed/28447016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-3485.203046 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|